BRIGID REILLY: Open Payments
NPI 1043065691 · HIXSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,925 in 173 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $623 · 2025 $2,925
Food & beverage: $2,925
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 63 | $846 |
| Regeneron Healthcare Solutions, Inc. | 9 | $318 |
| PFIZER INC. | 14 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $256 |
| Janssen Biotech, Inc. | 15 | $240 |
| Aimmune Therapeutics, Inc. | 9 | $236 |
| Celltrion USA Inc. | 10 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $159 |
| Madrigal Pharmaceuticals | 5 | $109 |
| Gilead Sciences, Inc. | 4 | $93 |
Products named: RINVOQ, DUPIXENT, TREMFYA, SKYRIZI, ZENPEP, XELJANZ, ENTYVIO, VEGZELMA.
Industry payments across TN — which companies pay providers there.
